Developing improved and scalable processes for active pharmaceutical ingredient of antiarrhythmic dronedarone hydrochloride and antidepressant escitalopram oxalate

Abstract

newline

Description

Keywords

Citation

item.page.endorsement

item.page.review

item.page.supplemented

item.page.referenced